Two French medtech companies are working together to develop a vascular graft for an artificial heart.
Ecouen, France-based Vygon will develop and manufacture a vascular graft for the outflow tract of Carmat's Aeson artificial heart. Vygon plans to adapt its existing polythese vascular graft to make it compatible with Carmat's device. The company will develop the two prosthetic outflow tracts connecting the artificial heart device to the patient's pulmonary arteries and aorta.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,